SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 11th, 2022 • Immunic, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 11th, 2022 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of October 10, 2022 by and among Immunic, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively, the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 2nd, 2016 • Aclaris Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 2nd, 2016 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of May 27, 2016 by and among Aclaris Therapeutics, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”).